Business
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
Tenured employees support St. Jude in finding cures and saving children LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus (Nasdaq: SLP) is celebrating 25
About this update from Simulations Plus, Inc.
[{"type":"text","content":"\nTenured employees support St. Jude in finding cures and saving children\n\n LANCASTER, Calif.--(BUSINESS WIRE)--\nSimulations Plus (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to St. Jude Children’s Research Hospital headquartered in Memphis, TN.\n\nDuring this 25th anniversary year, which commenced in July 2021, teams of long-tenured Simulations Plus employees researched various organizations and selected recipients aligned with the organization's vision and mission. This was our third $25,000 donation, and the group chose the internationally recognized St. Jude Children’s Research Hospital. The donation was made on June 17, 2022.\n\n“St. Jude creates more clinical trials for cancer than any other children’s hospital and turns laboratory discoveries into lifesaving treatments that benefit patients. This strongly aligns with our mission to optimize treatment options and improve patient lives,” said Shawn O’Connor, CEO of Simulations Plus.\n\n“Simulations Plus is committed to supporting organizations whose mission aligns with our core values. St. Jude’s commitment to developing innovative treatments that support children and families across the globe makes this a great addition to the charities we have supported as part of this program,” said Lindsay Luke, Executive Director of HR of Simulations Plus.\n\nAbout Simulations Plus\n\nServing clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | Twitter | YouTube.\n\nEnvironmental, Social, and Governance (ESG)\n\nWe focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report.\n\nAbo...